The partnership enables the integration of data from the Libre continuous glucose monitor (CGM) systems directly into Epic EHR in the U.S. Through this collaboration, the companies aim to improve workflow efficiency for providers through Epic’s Aura software. Aura brings health systems together with diagnostic labs and medical device manufacturers.
With the integration, data from a user’s LibreView account can automatically link to Epic. It enables clinicians to effortlessly view their patients’ glucose data within Epic before, during and after meeting with patients. This ensures healthcare providers can access key glucose data directly within their preferred workflows to enable more informed care.
“Our goal is to simplify care and drive better outcomes for both providers and patients,” said Lisa Earnhardt, EVP and group president of medical devices for Abbott. “While the integration with Libre data is Abbott’s first medical device offering with Epic, it’s just the beginning. We aim to expand this model to our other medical devices and connected care platforms in the future.”
Abbott says this brings access to critical glucose data to more than 575,000 U.S. healthcare providers serving 280 million patients.
“Our work with Abbott aims to make life simpler for the nearly 40 million people in the U.S. who live with diabetes today,” said Alan Hutchison, VP at Epic. “Diabetes requires close collaboration between patients, primary care providers, and specialists to manage a complex and time-critical care plan. This will help everyone focus more on patient care and less on administrative hurdles.”
